Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Dodecanoate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.90 |
| ▸ | PPARG | P37231 | 7/20 | 0.90 |
| ▸ | PPARD | Q03181 | 7/20 | 0.90 |
| ▸ | PPARA | Q07869 | 7/20 | 0.90 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.90 |
| ▸ | TSHR | P16473 | 4/20 | 0.90 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.90 |
| ▸ | FABP4 | P15090 | 3/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.90 |
| ▸ | TLR2 | O60603 | 2/20 | 0.90 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.90 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.90 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.90 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.90 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.90 |
| ▸ | MEN1 | O00255 | 1/20 | 0.90 |
| ▸ | ESR1 | P03372 | 1/20 | 0.90 |
| ▸ | PDE4A | P27815 | 1/20 | 0.90 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL29564580 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL30135415 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL29656950 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Dodecanoate SCHEMBL6561600 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL6563209 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL30605282 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL1830813 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Behenic Acid SCHEMBL6563203 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL2575032 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL30799574 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119286488-A | Non-acidic unblocking liquid system for unblocking oil and gas well and preparation method thereof | 中石化石油工程技术服务股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118291100-A | Oil-based drilling fluid and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118059778-A | Fluorescent microsphere with high load rate and preparation method thereof | 苏州星烁纳米科技有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117509926-A | Non-acidic descaling agent for well bore of gas well, and preparation and application thereof | 中国石油天然气股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-12350357-B2 | Active agents for skin and hair care with physicochemical modifying properties | SYMRISE AG (DE) | 2025-07-08 | — | — | US | disclosed |
| CN-119286488-A | Non-acidic unblocking liquid system for unblocking oil and gas well and preparation method thereof | 中石化石油工程技术服务股份有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-118059778-A | Fluorescent microsphere with high load rate and preparation method thereof | 苏州星烁纳米科技有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117509926-A | Non-acidic descaling agent for well bore of gas well, and preparation and application thereof | 中国石油天然气股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| US-20230293403-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-09-21 | — | — | US | disclosed |
| US-20230248626-A1 | Compositions Comprising (Bio)-Alkanediols | SYMRISE AG (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230129036-A1 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230131993-A1 | COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE THEREOF WITH IMPROVED STABILITY | SYMRISE AG (DE) | 2023-04-27 | — | — | US | disclosed |
| US-20230118435-A1 | COMPOSITION COMPRISING AN AVENANTHRAMIDE WITH IMPROVED SKIN PENETRATION | SYMRISE AG (DE) | 2023-04-20 | — | — | US | disclosed |
| US-20220105016-A1 | ACTIVE AGENTS FOR SKIN AND HAIR CARE WITH PHYSICOCHEMICAL MODIFYING PROPERTIES | SYMRISE AG (DE) | 2022-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230293403-A1 | Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols | CUTA, TRPA1, SMURF2 | GPR84 934/4885PPARG 418/4885PPARD 273/4885 |
| US-20230248626-A1 | Compositions Comprising (Bio)-Alkanediols | OR51E2, OR10J3, TRPA1 | GPR84 1523/4885PPARG 1517/4885PPARD 1528/4885 |
| US-20230129036-A1 | AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE | HPD, CYP4A22, PAH | GPR84 4057/4885PPARG 1318/4885PPARD 1197/4885 |
| US-20230131993-A1 | COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE THEREOF WITH IMPROVED STABILITY | OAT, PIGS, HLA-A | GPR84 3402/4885PPARG 491/4885PPARD 343/4885 |
| US-20230118435-A1 | COMPOSITION COMPRISING AN AVENANTHRAMIDE WITH IMPROVED SKIN PENETRATION | CUTA, ABCG2, MMP7 | GPR84 2150/4885PPARG 766/4885PPARD 682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.